Gregory Heberlein is a dedicated science professional currently serving as the Director of the Cell Therapy Platform Process at Bayer, where they lead cross-functional teams in the development and understanding of cell therapy. With an extensive background in biopharmaceuticals and biotechnology, Gregory has held various roles, including Associate Director at Kite Pharma and Head of Process Development at Altius Institute for Biomedical Sciences. They have a Master of Science in Biological Sciences from Clarion University of Pennsylvania and a Bachelor of Science in Biology from Slippery Rock University of Pennsylvania. Gregory is recognized for their ability to combine independent thinking with creativity to support their team and ensure project success.
This person is not in any teams
This person is not in any offices